Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003516988 | SCV004315422 | pathogenic | Alpha-N-acetylgalactosaminidase deficiency type 1 | 2023-09-22 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Met253Alafs*83) in the NAGA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NAGA are known to be pathogenic (PMID: 8782044, 11251574). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with NAGA-related conditions. For these reasons, this variant has been classified as Pathogenic. |